There is not a standardized procedure to treat primitive neuroectodermal tumors. Common strategies involve risk-adapted radiotherapy combined with chemotherapy and stem cell rescue. For patients younger than 2–3 years of age, treatment with radiation is not used, once they are in a more vulnerable phase and, thus, more prone to risks in development. Examinations such as CSF analysis and spinal MRIs are used to investigate the effectiveness of treatment in preventing metastasis. A method for eliminating tumorous mass is surgery, where the best outcome would be total resection, meaning the complete removal of the tumor. Along with the surgery, several measures that contribute to a safe procedure can be taken: urine exams, transfusion, and the constant supervision of arterial pressure. Possible problems that arise from the surgery include hemorrhage, brain edema, and hemiparesis. MRIs are typically done after 1 or 2 days of postoperative in order to inspect the amount of tumor remaining.
Central nervous system primitive neuroectodermal tumor
Central nervous system cyst
Extracranial germ cell tumor
Pediatric ependymoma
Primary central nervous system lymphoma
Primitive neuroectodermal tumor
Glial tumor
Central neurocytoma